Close menu




  • Quantitation of thrombin-activatable fibrinolysis inhibitor in human plasma by isotope dilution mass spectrometry – Analytical Biochemistry, 2022

  • Candidate High-Resolution Mass Spectrometry-Based Reference Method for the Quantification of Procalcitonin in Human Serum Using a Characterized Recombinant Protein as a Primary Calibrator – Analytical Chemistry, 94(10), 4146‑4154.. 2022

  • A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease – Brain Communications, 4(2). 2022

  • Accelerating the Validation of Endogenous On-Target Engagement and <em>In-cellulo</em> Kinetic Assessment for Covalent Inhibitors of KRAS G12C in Early Drug Discovery – bioRxiv. 2022

  • Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans – Clinical Pharmacology & ; Therapeutics, 109(6), 1575‑1582. 2021

  • Development of immunoprecipitation – two-dimensional liquid chromatography – mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients – Journal of Chromatography A, 1651, 462299. 2021

  • A Personalized Mass Spectrometry–Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM) – Clinical Cancer Research, 27(18), 5028‑5037. 2021

  • Mass Spectrometry Provides a Highly Sensitive Noninvasive Means of Sequencing and Tracking M-Protein in the Blood of Multiple Myeloma Patients – Journal of Proteome Research, 20(8), 4176‑4185. 2021

  • A Personalized Mass Spectrometry–Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM) – Clinical Cancer Research, 27(18), 5028‑5037. 2021

  • Simultaneous Quantification of Adalimumab and Infliximab in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry – Therapeutic Drug Monitoring: April 04, 2019

  • Direct quantitation of therapeutic antibodies for pharmacokinetic studies using immuno-purification and intact mass analysis – Bioanalysis. 2019: Vol 3 No3

  • An Internally Controlled Quantitative Target Occupancy Assay for Covalent Inhibitors – Nature Scientific Reports. 2018 Sep 25;8(1):14312
  • Simultaneous quantification of adalimumab and infliximab in human plasma by liquid chromatography-tandem mass spectrometry – Therapeutic Drug Monitoring. 2018 Aug;40(4):417-424.
  • Quantification of cardiac troponin I in human plasma by immunoaffinity enrichment and targeted mass spectrometry – Analytical Bioanalytical Chemistry. 2018 Apr;410(11):2805-2813
  • Quantitation of a Therapeutic Antibody in Serum Using Intact Sequential Affinity Capture, Trypsin Digestion, and LC-MS/MS – Analytical Chemistry. 2018 Jan 2;90(1):866-871
  • Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor – Cell. 2018 Jan 25;172(3):578-589.e17.
  • Introducing plasma/serum glycodepletion for the targeted proteomics analysis of cytolysis biomarkers – Talanta. 2017 Aug 1; 170:473-480
  • Multiplex and accurate quantification of acute kidney injury biomarker candidates in urine using Protein Standard Absolute Quantification (PSAQ) and targeted proteomics – Talanta. March 2017; 164: Pages 77-84
  • Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods? – Analytical Bioanalytical Chemistry. 2017 Feb;409(5):1195-1205
  • Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method – Journal Chromatography A. 2016 Jul 8; 1454:42-8.
  • Absolute and multiplex quantification of antibodies in serum using PSAQ™ standards and LC-MS – MS. Bioanalysis. 2015;7(10):1237-51
  • DIGESTIF: a universal quality standard for the control of bottom-up proteomics experiments – Journal Proteome Research. 2015 Feb 6;14(2):787-803.
  • Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry – Clinical Chemistry. 2014 Apr;60(4):683-9
  • Quantification of human growth hormone in serum with a labeled protein as an internal standard: essential considerations – Analytical Chemistry. 2014 Jul 1;86(13):6525-32.
  • The Role of Ion Mobility Spectrometry–Mass Spectrometry in the Analysis of Protein Reference Standards – Analytical Chemistry. 2013, 85 (15), pp 7205–7212
  • PSAQ™ standards for accurate MS-based quantification of proteins: from the concept to biomedical applications – J Mass Spectrometry. 2012 Oct;47(10):1353-63.
  • Development of a Protein Standard Absolute Quantification (PSAQ™) assay for the quantification of Staphylococcus aureus enterotoxin A in serum – Journal of Proteomics. 2012 Jun 6;75(10):3041-9.
  • Accurate quantification of cardiovascular biomarkers in serum using Protein Standard Absolute Quantification (PSAQ™) and selected reaction monitoring – Molecular Cellular Proteomics. 2012 Feb;11(2):M111.008235.
  • Production and use of stable isotope-labeled proteins for absolute quantitative proteomics – Methods Molecular Biology. 2011; 753: 93-115
  • Quantification of neutralizing anti-drug antibodies and their neutralizing capacity using competitive displacement and tandem mass spectrometry: Infliximab as proof of principle – Journal of Translational Autoimmunity. Volume 1, April 2019, 100004
  • Determination of Cetuximab in Plasma by Liquid Chromatography-High-Resolution Mass Spectrometry Orbitrap With a Stable Labeled 13C,15N-Cetuximab Internal Standard. – Ther Drug Monit. 2019 Aug;41(4):467-475.